EBV actively contributes to oncogenic changes by modifying the epigenetic profile of the host cell’s genome, particularly by targeting tumor suppressor genes such as E-cadherin, which is known to be epigenetically silenced in gastric carcinomas positive for the virus [18]. This evidence concerns the gene CDH1 and neoplasm.